| Source: |
| Type: |
| Brain-Derived Neurotrophic Factor (BDNF) is a key neurotrophin (a type of growth factor) involved in brain health, and its role in Alzheimer’s Disease (AD) has been extensively studied. -AD patients often have lower BDNF levels in key brain regions, such as the hippocampus and cortex. -This reduction correlates with cognitive decline and brain atrophy. -BDNF normally protects neurons from Aβ toxicity -Exercise and cognitive training have been shown to boost BDNF levels and may slow cognitive decline. - natural compounds (like curcumin or flavonoids) may also upregulate BDNF. |
| 4198- | SFN, | Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways |
| - | vitro+vivo, | AD, | NA |
| 4203- | SIL, | Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders |
| - | Review, | NA, | NA |
| 4204- | SIL, | Silymarin administration after cerebral ischemia improves survival of obese mice by increasing cortical BDNF and IGF1 levels |
| - | NA, | Stroke, | NA |
| 3318- | SIL, | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 4206- | SIL, | Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response |
| - | in-vivo, | NA, | NA |
| 4205- | SIL, | The Therapeutic Effect of Silymarin and Silibinin on Depression and Anxiety Disorders and Possible Mechanism in the Brain: A Systematic Review |
| - | Review, | AD, | NA |
| 4207- | SIL, | Silymarin sex-dependently improves cognitive functions and alters TNF-α, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury |
| 3049- | SK, | Shikonin Attenuates Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment by Inhibiting Apoptosis via PTEN/Akt/CREB/BDNF Signaling |
| - | in-vivo, | Nor, | NA | - | NA, | Stroke, | NA |
| 4216- | SSE, | Selenium ameliorates mercuric chloride-induced brain damage through activating BDNF/TrKB/PI3K/AKT and inhibiting NF-κB signaling pathways |
| - | in-vitro, | NA, | NA |
| 4215- | SY, | Safflower yellow alleviates cognitive impairment in mice by modulating cholinergic system function, oxidative stress, and CREB/BDNF/TrkB signaling pathway |
| - | in-vivo, | NA, | NA |
| 4151- | Taur, | Gins, | Taurine and Ginsenoside Rf Induce BDNF Expression in SH-SY5Y Cells: A Potential Role of BDNF in Corticosterone-Triggered Cellular Damage |
| - | in-vitro, | AD, | NA |
| 4157- | Taur, | Antidepressant dose of taurine increases mRNA expression of GABAA receptor α2 subunit and BDNF in the hippocampus of diabetic rats |
| - | in-vivo, | AD, | NA |
| 4172- | TQ, | Chronic Administration of Thymoquinone Enhances Adult Hippocampal Neurogenesis and Improves Memory in Rats Via Regulating the BDNF Signaling Pathway |
| - | in-vivo, | AD, | NA |
| 4173- | TQ, | Thymoquinone Can Improve Neuronal Survival and Promote Neurogenesis in Rat Hippocampal Neurons |
| - | in-vivo, | NA, | NA |
| 3790- | UA, | Therapeutic applications of ursolic acid: a comprehensive review and utilization of predictive tools |
| 3789- | UA, | Ex, | Combined Ursolic Acid and Resistance/Endurance Training Improve Type 3 Diabetes Biomarkers-Related Memory Deficits in Hippocampus of Aged Male Wistar Rats |
| - | in-vivo, | AD, | NA |
| 4860- | Uro, | Urolithins–gut Microbial Metabolites with Potential Health Benefits |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 4878- | Uro, | Activation of the Gut–Brain Interaction by Urolithin A and Its Molecular Basis |
| - | Review, | AD, | NA |
| 4880- | Uro, | Urolithins: A Prospective Alternative against Brain Aging |
| - | Review, | AD, | NA |
| 4181- | VitB6, | Vitamin B6 prevents cognitive impairment in experimental pneumococcal meningitis |
| - | in-vivo, | NA, | NA |
| 4183- | VitD3, | Ex, | Combined Exercise and Vitamin D on Brain-Derived Neurotrophic Factor |
| - | Review, | NA, | NA |
| 4184- | VitD3, | Neuroplasticity-related effects of vitamin D relevant to its neuroprotective effects: A narrative review |
| - | Review, | NA, | NA |
| 4185- | VitD3, | Effects of vitamin D supplementation on neuroplasticity in older adults: a double-blinded, placebo-controlled randomised trial |
| - | Study, | NA, | NA |
| 4186- | VitD3, | The Association of Vitamin D, Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), and Glial Cell-Derived Neurotrophic Factor (GDNF) with Development in Children |
| - | Study, | NA, | NA |
| 4187- | VitD3, | Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF) |
| - | in-vivo, | NA, | NA |
| 4182- | VitD3, | The association between vitamin D and BDNF on cognition in older adults in Southern Brazil |
| - | Study, | AD, | NA |
| 4179- | VitE, | Vitamin E protects against oxidative damage and learning disability after mild traumatic brain injury in rats |
| - | in-vivo, | NA, | NA |
| 4188- | VitK2, | Vitamin K2 protects against aluminium chloride-mediated neurodegeneration |
| - | in-vivo, | NA, | NA |
| 4196- | Z, | The effect of zinc supplementation on brain derived neurotrophic factor: A meta-analysis |
| - | Review, | NA, | NA |
| 4197- | Z, | The Effect of Zinc Supplementation on Circulating Levels of Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| - | Review, | NA, | NA |
| - | Trial, | Obesity, | NA |
| 4165- | Z, | Antidepressant-like activity of zinc: further behavioral and molecular evidence |
| - | in-vivo, | AD, | NA |
| 4164- | Z, | Zinc treatment induces cortical brain-derived neurotrophic factor gene expression |
| - | Review, | AD, | NA |
| 4191- | Zeax, | Lut, | Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance |
| - | Trial, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1356 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid